Chronic Non-Bacterial Osteomyelitis Presenting as Fever of Unknown Origin in a Child: A Diagnostic Pitfall

Why It Matters

Recognizing CNO as a fever‑of‑unknown‑origin cause can curb costly invasive testing and improve pediatric patient outcomes, highlighting a critical gap in current diagnostic pathways.

Key Takeaways

• CNO can present primarily as fever, not bone pain
• Imaging may mimic malignancy, leading to misdiagnosis
• Biopsy essential to rule out infection and cancer
• Early CNO identification avoids unnecessary invasive procedures
• Awareness reduces healthcare costs and diagnostic delays

Pulse Analysis

Chronic non‑bacterial osteomyelitis (CNO) remains a diagnostic blind spot in pediatrics because its hallmark bone pain can be eclipsed by systemic fever. When fever dominates the clinical picture, clinicians often launch exhaustive infectious and oncologic workups, as seen in the reported 12‑year‑old patient. This approach not only prolongs the time to appropriate therapy but also inflates healthcare expenditures through repeated imaging, advanced sequencing, and invasive procedures that ultimately prove non‑diagnostic. Raising clinical suspicion for CNO in fever‑of‑unknown‑origin (FUO) algorithms can streamline evaluation and preserve resources.

Advanced imaging modalities such as MRI and PET‑CT are double‑edged swords in CNO assessment. While they sensitively detect multifocal bone marrow inflammation, their hypermetabolic signatures closely resemble those of malignant lesions, prompting unnecessary oncologic referrals. The case illustrates that definitive diagnosis hinges on histopathology; a targeted bone biopsy revealed characteristic lymphoplasmacytic infiltrates and excluded infection and neoplasm. Incorporating early, minimally invasive biopsy protocols when imaging suggests malignancy can truncate the diagnostic odyssey, reduce patient anxiety, and limit exposure to radiation and anesthesia.

From a health‑system perspective, integrating CNO awareness into FUO guidelines offers tangible cost‑saving opportunities. Early identification curtails the cascade of high‑priced tests and hospital stays, aligning with value‑based care initiatives. Moreover, educating pediatric rheumatologists and emergency physicians about CNO’s atypical presentations can foster timely referrals to specialty centers, improving long‑term outcomes for affected children. As precision medicine advances, leveraging biomarkers and standardized imaging criteria may further differentiate CNO from malignancy, reinforcing its place in the differential diagnosis of pediatric fever.